BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Shionogi & Co., Ltd. 

1-8, Doshomachi 3-Chome
Chuo-ku
Osaka     541-0045  Japan
Phone: 81-0-6-6202-2161 Fax: 81-0-6-6229-9596


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Research





 Company News
Shionogi & Co., Ltd. Presents Pre-Clinical And Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat Multidrug-Resistant Gram-Negative Pathogens 9/8/2014 10:34:54 AM
Shionogi & Co., Ltd. Enlists BuzzeoPDMA, A Cegedim Company To Support Their Sample Management Compliance Programs 9/4/2014 11:09:07 AM
GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test 7/11/2012 6:44:43 AM
Shionogi & Co., Ltd. and Shionogi, Inc. Announce a Favorable Decision In FORTAMETĀ® Preliminary Injunction Proceedings 12/7/2011 8:43:56 AM
Shire plc Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd. 11/18/2011 10:38:15 AM
MorphoSys AG and Shionogi & Co., Ltd. Agree Three-Year Extension of Research Partnership 11/2/2011 8:37:48 AM
Evotec AG (EVTG.F) Achieves Two Milestones in Fragment-based Drug Discovery Alliance With Shionogi & Co., Ltd. 10/27/2011 10:16:12 AM
Japan's Shionogi & Co., Ltd. to Acquire C&O Pharmaceutical Technology for About $182 Million 8/1/2011 8:05:28 AM
Shionogi & Co., Ltd. Announces Commercial Availability of CUVPOSA(TM) (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 4/7/2011 6:31:09 AM
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Collaboration with Shionogi & Co., Ltd. 3/30/2011 9:22:32 AM
123456